Sponsored By

Specialty in vivo plastics fuel Biomerics' expansions

Biomerics (Salt Lake City, UT), which announced completion of a cleanroom expansion earlier this week, will expand even further this year, a company official tells Plastics Today in an interview.

March 8, 2012

2 Min Read
Specialty in vivo plastics fuel Biomerics' expansions

Biomerics (Salt Lake City, UT), which announced completion of a cleanroom expansion earlier this week, will expand even further this year, a company official tells Plastics Today in an interview.

"Over the next nine months, we expect to add another 5-10 people, add two more injection molding machines and add compounding equipment," says Troy Mohr, vice president of business development  for

Polyimide tubes are extruded for in vivo applications. Photo: Biomerics

the company.

Behind the growth is growing demand for specially compounded and processed biomaterials for use inside the human body (in vivo), a field that many large resin companies have conspicuously avoided because of potential liability issues.

Biomerics was founded in 1994, as Utah Plastics Group with three employees and one customer. It entered the medical market as a regional custom molder and gradually expanded molding capabilities and added machining, tooling, cast molding, extrusion, and compounding capabilities.  The company introduced proprietary biomaterials in 2008 and changed its name to Biomerics.

Molding, assembly, packaging

The 10,000-square-foot expansion at its Salt Lake City plant announced this week includes an ISO Class 8 clean room for injection molding and device assembly, a medical device packaging cell, and a fulfillment warehouse. Biomerics now operates 25 injection molding machines and has a production partnership with a Rhode Island processor.

"The additional clean room enables us to have dedicated production areas for material polymerization and compounding, as well as injection molding and medical device assembly," says Travis Sessions, president and CEO of Biomerics. "The new packaging and warehouse space expands our capability to manage sterile medical device fulfillment for our customers."

In the past six months, Biomerics has brought online new medical and pharma compounding lines, an automated material handling system, and expanded capabilities in injection molding, vibration welding, and device assembly.

The expansion of this ISO 13485 registered facility has resulted in the hiring of 15 employees and is expected to create additional positions over the next 12 months, says Mohr.

Extrusion specialties include multi-lumen tubing, bump tubing, polyimide tubing, and jacketing. Biomerics operates 12 production extrusion lines (3/4" to 2") and two R&D extrusion lines.

Its proprietary thermoplastic polyurethane (TPU) formulations are sold under the following brand names: Quadrathane, Quadraflex, Quadraplast, Quadraphillic, and Quadraban.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like